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doi:10.1016/j.jtcvs.2006.04.033bjective: Pressure distention of veins during preparation for bypass surgery is
elieved to impair vascular integrity and reduce graft patency. We previously
uggested a combination of pharmacologic vasodilatators as an alternative to dis-
ention. Vascular homeostasis is largely regulated by nitric oxide. We investigated
he role of distention in comparison with pharmacologic vasorelaxation in the
egulation of nitric oxide synthases, nitric oxide bioavailability, and vascular reac-
ivity in vein grafts.
ethods: In a porcine model the internal jugular vein from either side received
ressure distention or the combination of vasodilators (-adrenergic antagonist,
henoxybenzamine, 10 mol/L; Rho-kinase inhibitor, HA-1077 [fasudil], 50
mol/L; calcium blocker, nicardipine, 1 mol/L) and then was grafted into the
arotid artery. Regulation of nitric oxide synthase, as well as nitrate and nitrite
evels, were examined in vein grafts after 2 weeks of implantation.
esults: Distention of jugular veins resulted in reduction of vasoconstriction in
esponse to depolarization and agonist stimulation. Arterial grafting doubled induc-
ble nitric oxide synthase expression in both grafts but caused a pronounced
pregulation of endothelial nitric oxide synthase protein (by 57.3%  5%) only in
rug-treated grafts, whereas in distended grafts the endothelial nitric oxide synthase
evel was decreased by 27.5%  2.7%. The downregulated endothelial nitric oxide
ynthase level in the distended grafts was accompanied by a 45.2%  3.1%
eduction of phospho–endothelial nitric oxide synthase Ser1177 levels and by a
ignificant reduction in nitric oxide synthase activity (12.1%  1.2%) and nitrate
roduction (48.9%  5.6%) in comparison with that seen in drug-treated grafts.
onclusions: Pharmacologic preparation of the vein grafts results in upregulation of
ndothelial nitric oxide synthase and increased nitric oxide production in the vein
rafts after arterial implantation. This might provide greater clinical benefit than
onventional pressure-distention methods.
he saphenous vein (SV) is a commonly used conduit for cardiac and
peripheral revascularization. Because of its long length and the ease of
harvesting, the demand for SVs in grafting remains high. However, it is
pasmodic and is routinely distended during preparation for grafting to overcome
asospasm. This procedure might result in lower vein graft patency.1,2
High pressure-distention immediately and irreversibly impaired vascular con-
ractility and endothelial function3,4 resulting in reduced bioavailability of nitric
xide (NO),5 and endothelial and medial NO synthases (NOSs),6 and a decrease in
mooth muscle cell (SMC) response to relaxant signaling.7 Serious damage of the
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CSPndothelial lining after manual flushing and distention has
een found in earlier investigations.8,9 Distended veins also
xhibited increased platelet and leukocyte adhesion,10 ex-
essive extracellular matrix accumulation in the neointi-
a,11 and activation of proliferation signaling (unpub-
ished data), underlying the accelerated development of
eointima.10
NO is crucial in regulating graft remodeling not only for
ts role in control of blood flow, but also for its inhibitory
ffects on SMC proliferation and adhesion and its proan-
iogenic12 role, which alleviates the consequences of isch-
mia. In the vasculature NO is mostly synthesized by the
onstitutively expressed endothelial NOS (eNOS) and the
nducible NOS (iNOS). Hence the production of NO has
een found to be dysfunctional after balloon injury and in
ein grafts when vascular SMC proliferation and neoin-
ima formation are progressing, and a deficit of NO has
een implicated in decreased proliferative modification
f vascular SMC.13-15 Therefore, downregulation of NOS
nd the consequent reduced NO production resulting from
ressure distention of vein grafts could contribute to throm-
osis and neointima development. However, the effects of
istention on the regulation of NOS in vein grafts are less
tudied.
Because of the high susceptibility of human SVs to
asoconstriction,3,4 pressure distension during surgical prep-
ration for grafting cannot be abolished without replace-
ent with an alternative procedure to prevent vasospasm.
e have suggested the topical application of a combination
f effective pharmacologic vasodilatators as an alternative
o pressure distention.4,11 In the present study we investi-
ated the effect of pressure distention compared with phar-
acologic vasorelaxation of vein grafts on the regulation of
OS and the production of NO in a porcine vein graft
odel. We hypothesized that pressure distention of the
eins compromised vascular integrity and the NO system by
ausing downregulation of NOS (Figure 1).
aterials and Methods
orcine Bypass Grafting
ll animal procedures were approved by the University of British
olumbia Animal Care Committee. Reversed segments of jugular
eins were grafted into the carotid arteries of 8 female white pigs
Abbreviations and Acronyms
eNOS endothelial nitric oxide synthase
iNOS  inducible nitric oxide synthase
NO  nitric oxide
NOS  nitric oxide synthase
SMC  smooth muscle cell
SV  saphenous veinweight, 60-65 kg). Pigs were given a general anesthetic (a single 
26 The Journal of Thoracic and Cardiovascular Surgery ● Octoose of ketamine, 800-1400 mg), and under sterile conditions, a
idline neck incision was made to expose both the common
arotid and internal jugular veins. Six-centimeter segments of the
eins were dissected from each side and randomized to receive
ressure distension or immersion in a vasodilatory solution. Veins
andomized to pressure distension were distended with physiologic
olution at 300 mm Hg for 2 minutes, and a segment was cut as a
istended vein sample. From the vein randomized to the vasodi-
atory solution, a piece (4 mm) was cut as a nondistended vein
ample, and the rest was placed in a bath containing a combination
f vasodilatatory drugs (-adrenergic antagonist, phenoxyben-
amine, 10 mol/L; Rho-kinase inhibitor, HA-1077 [fasudil], 50
igure 1. A, An illustration showing the beneficial effects of nitric
xide (NO). In the vasculature NO is generated from L-arginine by
oth constitutive and inducible NO synthase (endothelial NO
ynthase (eNOS) in endothelium and inducible NO synthase
iNOS) in smooth muscle cells (SMCs)). NO exerts its protective
ffects by inducing smooth muscle relaxation; inhibiting SMC
roliferation, migration, and synthesis of extracellular matrix
ECM); inhibiting platelet and leukocyte activation and adhesion;
nd stimulating endothelial cells proliferation. B, We hypothesize
hat the replacement of pressure distention with pharmacologic
asodilatators in vein grafting preserves endothelium and NO
ormation in the vein graft. The augmented bioavailability of NO
ould be beneficial to suppress vascular remodeling and vein
raft occlusion.mol/L; calcium blocker, nicardipine, 1 mol/L) for 30 min-
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Ptes.4,11 After either pressure distension or a vasodilatory bath, the
eins were grafted to the divided carotid artery by using an
nd-to-end anastomotic technique as an interposition vein graft.
fter 2 weeks, the 7 pigs that survived the operation were given
nother general anesthetic, and the interposition vein grafts
ere harvested. The drug-treated graft was considered as a
ontrol for damaging pressure distention. All animals were then
illed.
istology
epresentative segments were formalin fixed and embedded in
araffin, and 3-m cross-sections were prepared and stained with
ntibodies against von Willebrand factor (dilution 1:400), which
abel endothelium and allow us to evaluate its thickness and
ntegrity, and with Movat pentachrome, which labels SMCs, elas-
in, and other extracellular matrix components in the vessels.
mage acquisition and processing was performed with a Nikon
icroPhot microscope (Nikon Inc, Garden City, NY), and images
ere captured by using a SPOT digital camera (Diagnostic Instru-
ent Inc, Sterling Heights, Mich).
asomotor Function and Elasticity
or studying vasomotor function, 3-mm vein segments were sus-
ended between 2 stainless-steel clips, placed for 2 hours in
lass-jacketed tissue baths containing oxygenated physiologic
uffer saline (pH 7.4) at 37°C, and equilibrated as described
reviously.3 One of the clips was connected to a force transducer,
nd the force was registered with A/S Myotechnology Myograph
Aarhus N, Denmark). The contraction of the vessels was stimu-
ated with 50 mol/L phenylephrine.
Endothelium-dependent relaxation was studied, with acetyl-
holine (10 nmol/L to 3 mol/L, median effective concentration
00 nmol/L) added in a cumulative manner to the precontracted
eins.
The vessel elasticity was elucidated from the length-tension
urves, which were obtained by measuring the passive tension
hile gradually increasing the circumferential length of the
essel segments. Data acquisition and analysis were as previously
escribed.3,4
everse Transcription Polymerase Chain Reaction
otal RNA was extracted from the flash-frozen samples by using
RIzol reagent (Invitrogen Life Technologies, Carlsbad, Calif).11
NA (1 g) was subjected to reverse transcription by using
oloney murine leukemia virus reverse transcriptase, ribonu-
lease inhibitor, and random primers (Invitrogen).11 Reverse tran-
cription reaction mixture (5 L) was used in the polymerase
hain reaction experiments with the addition of AmpliTaq Gold
NA polymerase (Applied Biosystems, Foster City, Calif) and
ene-specificprimers foreNOS(forward:CAG-TGT-CCA-ACA-
GC-TGC-TGG-AAA-TTG, reverse: TAA-AGG-TCT-TCT-TCC-
GG-TGA-TGC-C, 485 bp) and iNOS (forward: GGC-CTC-GCT-
TG-GAA-AGA, reverse: TCC-ATG-CAG-ACA-ACC-TT, 499
p). The reference gene -actin, which is expressed in vascular
ell types (forward: CAG-GCA-CCA-GGG-CGT, reverse: ATG-
CT-GGG-GTG-TTG-AAG, 282 bp) served as a control to en-ure equal sample loading (NAPS Unit Oligonucleotide Syn- r
The Journal of Thoracichesis Laboratory, Biotechnology Laboratory, The University of
ritish Columbia).
estern Immunoblotting
lash-frozen segments were ground with liquid nitrogen in a
tainless-steel mortar and pestle. Tissue powder was mixed in 9
olumes of ice-cold lysis buffer (50 mmol/L Tris-HCl, pH 7.4,
ith 3.1 mmol/L sucrose, 1 mmol/L dithiothreitol, 10 g/mL
eupeptin, 10 g/mL soybean trypsin inhibitor, 2 g/mL aprotinin,
nd 0.1% Triton X-100). After 20 minutes of incubation on ice,
amples were homogenized with a glass homogenizer. Protein
amples (10 g) were separated on a 7% sodium dodecylsulfate–
olyacrylamide gel electrophoresis and transferred to polyvinyl
ifluoride membranes (Biorad, Hercules, Calif).11 Membranes
ere incubated with mouse monoclonal anti-eNOS, anti-iNOS
dilution 1:1000; BD Biosciences, Mississauga, Ontario, Canada),
r rabbit polyclonal anti-phospho-eNOS Ser1177 (dilution 1:1000;
ell Signaling, Beverly, Mass) antibodies for 2 hours, followed by
orseradish peroxidase–labeled secondary anti-mouse or anti-
abbit IgG antibodies (dilution 1:2500) for 1 hour. Immunoreactive
rotein was visualized by using an enhanced chemiluminescence kit
Amersham Life Sciences, Buckinghamshire, United Kingdom).
easurement of NOS Activity and Concentrations
f Nitrate and Nitrite
O concentration and activity of eNOS and iNOS in protein
xtract (30 g) was determined colorimetrically by using an NOS
ssay kit (Calbiochem, San Diego, Calif). NO was assayed by
easuring the sum of concentrations of nitrate (NO3) and nitrite
NO2), the oxidation products of NO, which were quantified
olorimetrically relative to a nitrate standard curve.
aterials
ll other reagents were of the highest molecular grade and pur-
hased from Sigma (St Louis, Mo), unless otherwise stated.
tatistics
ata were reported as means  standard error of the mean from 8
ndependent experiments. Statistical analysis was performed with
raphPad Prism software (San Diego, Calif). Differences between
roups were studied by means of 1-way analysis of variance.
esults
asomotor Function, Morphology, and
essel Elasticity
istention irreversibly decreased the contractile response of
he jugular vein to -adrenergic stimulation and depolariza-
ion to about 10% of the original value and abolished
asorelaxation in response to acetylcholine (Figure 2, A).
he presence of the endothelial layer, on average, was not
hanged significantly (Figure 3, A-C), although on some
ross-sections endothelial cells appeared to be separated
rom each other. On Movat-stained sections, elastin (the
lack fibril structure) was present throughout the media as
ontinuous circumferentially oriented bands, which sepa-
ated SMC layers (Figure 3, D and E). Distention disrupted
and Cardiovascular Surgery ● Volume 132, Number 4 927
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CSP
he organized fibril structure of elastin, which appeared as
iscontinuous elastin fragments (Figure 3, E). The effect of
istention on the elastic properties studied in parallel showed
hat the distended vein markedly lost elasticity (Figure 2, B).
egulation of NOS Expression and Activity
either distention nor arterial implantation modified eNOS
ene transcription in vein grafts (Figure 4, A), whereas
NOS transcription, not detected before grafting, was mark-
dly upregulated in both postgrafts (Figure 4).
Although pressure distention did not instantly affect the
rotein expression of eNOS, different protein levels were
igure 2. Vasomotor properties. A, Contraction of porcine undis-
ended and distended veins in response to -adrenergic stimu-
ation (50 mol/L phenylephrine [PE] ) and acetylcholine (Ach)–
nduced relaxation (10 nmol/L to 3 mol/L) and contraction
nduced by depolarization (80 mmol/L K). B, Length-tension
urves of an undistended (dotted line) and a distended (solid line)
orcine vein. Results are representative of 6 similar experiments.bserved in 2 postgrafts. In comparison with the pregrafted h
28 The Journal of Thoracic and Cardiovascular Surgery ● Octoevel, eNOS expression in drug-treated grafts was increased
y 57.3%  5.0%, whereas in distended grafts it was
ecreased by 27.5%  2.7%. eNOS enzymatic activity was
nhanced by phosphorylation at Ser1177, and its phosphor-
lation level was highly upregulated by 110% 18% in the
rug-treated grafts. Phosphorylation of eNOS in the dis-
ended grafts remained at the pregrafted level. Thus the
NOS protein expression and phosphorylation levels in the
istended postgrafts were about half of those in the drug-
reated grafts (Figure 5, A and C).
The iNOS protein levels in both veins were approxi-
ately doubled after grafting (Figure 5, B). Both postgrafts
emonstrated increased NOS activity, but the drug-treated
rafts had a significantly higher NOS activity than the
istended grafts by 12.1%  1.2% (Figure 6).
egulation of NO Production
O is readily oxidized to form NO3 and NO2, and
herefore NO production was measured as the sum of these
xidation products. Arterial implantation differentially reg-
lated NO production in 2 grafts, with NO production being
ncreased in drug-treated grafts by 20.3%  4.4% but re-
uced in distended grafts by 17.0%  3.2%. Because disten-
ion had a small inhibitory effect on the pregrafted vein, the
O production in the drug-treated grafts was 48.9%  5.6%
igure 3. von Willebrand factor–stained cross-sections from un-
istended (control, A) and distended (B and C) veins indicating
he presence of endothelial cells. Movat-stained sections show-
ng the elastin fibril structure (black) in the undistended (D) and
istended (E) veins. Scale bars 0.05 mm. Representative images
rom 7 to 8 independent experiments are shown.igher than in the distended grafts (Figure 6).
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Piscussion
he present study reveals the effects of pressure distention
n comparison with pharmacologic vasodilatation and arte-
ial hemodynamics on the regulation of NOS in a porcine
ein graft model. After 2 weeks of implantation into the
rterial circulation, eNOS expression and phosphorylation
ere markedly less in the distended grafts compared with
he drug-treated ones and were associated with lower levels
f NOS activity and NO production. The inducible enzyme
NOS, which was undetectable in the veins before grafting,
as equally induced during implantation in both types of
rafts but did not compensate for the reduced NO genera-
ion in the vascular tissue of the distended grafts.
Distention with moderate pressure (eg, 300 mm Hg)
rastically affected the veins both structurally and function-
lly. It overstretched the veins, and as a result, the vessels
rreversibly lost their contractile ability and passive elastic-
ty. The loss of the contractile responses to depolarization
ith 80 mmol/L K and to the -adrenergic receptor ago-
ist phenylephrine demonstrates the impairment of the
MCs (Figure 2, A). The loss of elasticity could be due to
oth damage to the SMCs and the fracture of the elastin
brillar structure (Figure 2, B).16
Denudation of the endothelial cells was not observed at
his pressure. Although some von Willebrand factor–stained
lides of the distended veins showed discontinuity in the
Figure 5. Regulation of nitric ox-
ide synthase expression in vein
grafts prepared by pressure dis-
tention and pharmacologic vaso-
dilatators. Densitometric mea-
surement of protein expressions
of endothelial nitric oxide syn-
thase (eNOS; A), inducible nitric
oxide synthase (iNOS; B), and
phospho-eNOS Ser1177 (C) is
shown. Insets, representative im-
munoblots showing eNOS, iNOS
phospho-eNOS Ser1177, and -actin
immunoreactivity. *P < .05.igure 4. Regulation of gene transcription of endothelial nitric
xide synthase (eNOS) and inducible nitric oxide synthase (iNOS)
n vein grafts prepared by pressure distention and pharmacologic
asodilatators. A, Representative polymerase chain reaction
esults showing the mRNA transcription of eNOS, iNOS, and
-actin (loading control). B, Bar chart is the densitometric mea-
urement of iNOS transcription.and Cardiovascular Surgery ● Volume 132, Number 4 929
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CSPndothelial layer, the average density of endothelium did
ot differ between the distended and nondistended veins
Figure 3, A-C). The unchanged level of eNOS protein
mmediately after distention (Figure 5, A) confirmed the
bsence of the endothelial cell loss. However, the endo-
helial cells were still modified by distention. Although it
s difficult to detect the absence of the relaxation stimu-
ated with acetylcholine at such a low level of contraction
Figure 2, A), the decreased eNOS expression after 2 weeks
f grafting reveals the original effect of distention on the
ndothelial cells. Thus moderate distension did not cause
e-endothelialization but still modifies cells, resulting in
rolonged detrimental effects.
Grafting for 2 weeks significantly increased the eNOS
xpression in the drug-treated grafts, while downregulating
ts expression in those that were pressure distended. Phos-
horylation of eNOS Ser1177 was increased by 110% in the
rug-treated grafts. These levels of expression and phos-
horylation were at least 2-fold higher in the drug-treated
rafts than in the distended grafts. eNOS levels have pre-
igure 6. Enzymatic activities of nitric oxide synthase (NOS) and
oncentrations of nitrate and nitrite determined by using a col-
rimetric assay. Bar charts are the averaged NOS activities
upper panel) and the sum of concentrations of nitrate and nitrite
lower panel). *P < .05.iously been found to be significantly increased in SV grafts d
30 The Journal of Thoracic and Cardiovascular Surgery ● Octoompared with those seen in ungrafted veins,7 but the effect
f distention was not examined in that study. The difference
n the regulation of eNOS between 2 types of grafts was not
ttributable to change in gene transcription, so that the
iscrepancy between eNOS mRNA and eNOS protein dem-
nstrates complex regulatory mechanisms at the posttran-
criptional level, the posttranslational level, or both.
In contrast, the protein expression of iNOS was doubled
fter arterial implantation, regardless of the preparatory
rocedures of the veins before grafting, and this was highly
orrelated to the upregulated gene transcription (Figure 4).
his indicated that the inflammatory response triggered by
urgical trauma and arterial hemodynamics masked the ef-
ect of the initial distention. However, the upregulated iNOS
evels could not compensate for the effect of decreased
NOS levels with respect to either NOS activity or NO
roduction. The NOS activity and NO production were not
hanged in the veins immediately after distention but were
ignificantly higher in the drug-treated grafts than in the
istended grafts (Figure 6). Because NO has an extremely
hort half-life, its local distribution and subsequent effects
argely depend on the NOS expression. Thus NOS activity
nd NO production principally reflected the total levels of
NOS plus iNOS expression.
This study characterized the NO regulation in the grafts
fter arterial implantation of the distended and nondistended
eins. Cellular mechanisms of vascular remodeling, includ-
ng NO regulation, have been studied more extensively in
alloon-injured arteries than in bypass vein grafts. NO is
nown to inhibit platelet aggregation and expression of
dhesion molecules, and this antiatherogenic property might
educe the period during which the vein graft is vulnerable
o thrombosis.17-20 In late graft failure NO might play a role
n the reduction of intimal hyperplasia because it is impli-
ated in the attenuation of vascular SMC proliferation and
igration13-15 and the development of atherosclerosis.21
urthermore, the higher NO formation in the internal tho-
acic artery compared with the SV underlies a better early
nd long-term patency of this conduit vessel over the SV in
oronary bypass grafting (Figure 1).22 Our recent data re-
ealed that the drug-treated grafts exhibited reduced neoin-
ima formation, which could be attributed to the increased
evels of NO (Figure 6). Therefore the replacement of
istention with pharmacologic relaxation, which results in
igher levels of NO in the grafts, could contribute to the
eduction in neointima development and possibly improved
ein graft patency.
iNOS is known to be induced after injury and potently
ontributes to NO production. It has been identified within
he media 1 day after balloon injury but was confined to
eointimal SMCs by 1 to 2 weeks.23 It could compensate for
he loss of NO as a result of endothelial damage and
ownregulated eNOS levels.24 However, eNOS and iNOS
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Pight differentially regulate vascular remodeling during
ein graft failure. It has been suggested that NO from eNOS
nhibited neointimal formation, whereas NO from iNOS
uppressed the development of constrictive remodeling, de-
ned as the reduction of the cross-sectional vascular area.25
The avoidance of distention resulted in a beneficial in-
rease of NO production. In previous studies endothelial
amage was observed after manual distention and flushing
f vessels.8,9 However, we did not detect acute denudation
f endothelial cells either in human veins4 or in the present
tudy after distention of porcine veins. This was probably
ue to the moderate pressure and the absence of a flushing-
ut rinse; nevertheless, the consequences of eNOS in the
istended veins were still detected after grafting. It has been
hown that human SVs harvested by means of either the
inimally invasive technique or the traditional open dissec-
ion technique preserve the endothelial relaxation response
nd SMC contractile function if the veins were not subject
o distention.26 Application of a no-touch harvesting tech-
ique of SVs, in which the vein is harvested with a pedicle
f surrounding tissue and not distended, also preserved the
ndothelial integrity and function.6 NOS content was higher
n the SVs harvested by this technique than in SVs har-
ested by the conventional procedure including distention,6
nd distention is suggested to have a detrimental effect on
uminal endothelial and medial NOS levels.
Pressure distention, unfortunately, cannot be avoided
ithout replacement with an alternative technique to over-
ome vasospasm. We used a combination of pharmacologic
asodilatators, which appeared to be potently antispasmodic on
uman SVs.4 The pharmacologic cocktail might contribute to
he effects observed in this study. For instance, the Rho-kinase
nhibitor fasudil has been demonstrated to reverse hypoxia-
nduced downregulation of eNOS mRNA, protein expression,
nd activity in human SV endothelial cells.27
In conclusion, we demonstrated that pressure distention
f veins during surgical preparation for grafting, compared
ith treating the veins with a combination of vasodilatory
rugs, resulted in reduced eNOS expression and phosphor-
lation and low NOS activity and NO production in vein
rafts after arterial implantation. This study supports the
ypothesis that avoidance of pressure distention by using
harmacologic vasodilatation constitutes a feasible clinical
echnique for augmenting NO production by the vein graft
nd eventually improving graft patency.
The first limitation of this study is the relatively small
umber of experimental animals. However, our study was
f sufficient statistical power to delineate differences in
OS expression and NO levels between the distended and
rug-treated grafts. Furthermore, the conclusions of our
tudy are based not on the analysis of a single variable but
n several parameters (gene transcription, protein expres-
ion, activity, and NO level). Second, the assay kit for
1
The Journal of Thoraciceasuring NO concentration and NOS activity has a mea-
uring limit at micromolar range. Compared with a porphy-
inic nanosensor, which is able to directly measure NO at a
anomolar range of concentration, this colorimetric NO
easurement assay is relatively insensitive, which is prob-
bly related to the indirect measurement of NO from the
um of the levels of nitrate and nitrite. In addition, using this
it does not allow one to distinguish the contributions of
ach NOS in the NO production.
We thank Mr Serge Okon for his help with image acquisition
nd analysis.
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